Skip to main content

CORRECTION article

Front. Public Health, 30 November 2022
Sec. Public Health Policy
Volume 10 - 2022 | https://doi.org/10.3389/fpubh.2022.1083211

Corrigendum: Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030

This article is a correction to:

  1. Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030

    1. Read original article
\nBule Shao &#x;Bule Shao1*†Wenjing Yang&#x;Wenjing Yang2†Qian Cao Qian Cao1*
  • 1Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 2Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China

A corrigendum on
Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030

by Shao, B., Yang, W., and Cao, Q. (2022). Front. Public Health 10:1032679. doi: 10.3389/fpubh.2022.1032679

In the published article, there was an error in Figure 2 and Supplementary Figure 1 as published. The same typos when generated by the R software to PDF, i.e., the X-axis label “≥ 95” was incorrectly generated as “= 95”. Although the typos will not affect the results and conclusions of the manuscript, the authors would like to upload the correct version of the figures for better reading experiences for readers.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: disease burden, China, prediction, public health, inflammatory bowel disease, age-period-cohort analysis

Citation: Shao B, Yang W and Cao Q (2022) Corrigendum: Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030. Front. Public Health 10:1083211. doi: 10.3389/fpubh.2022.1083211

Received: 28 October 2022; Accepted: 31 October 2022;
Published: 30 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Shao, Yang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bule Shao, c2hhb2JsJiN4MDAwNDA7emp1LmVkdS5jbg==; Qian Cao, Y2FvcSYjeDAwMDQwO3pqdS5lZHUuY24=

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.